VM
Vijay Mathodu Eshwarappa
About Vijay Mathodu Eshwarappa
Data last updated:
Vijay Mathodu Eshwarappa has 11 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Impilo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Impilo Pharmaceuticals Private Limited at ₹51.2 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 05 Jan 2015 | 2015 | ₹51.2 Lakh (FY 2019) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Mathodu Eshwarappa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Mathodu Eshwarappa
Vijay Mathodu Eshwarappa has 11 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Impilo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Impilo Pharmaceuticals Private Limited at ₹51.2 Lakh (FY 2019).
Vijay Mathodu Eshwarappa is associated with 1 company as Whole-Time Director, including Impilo Pharmaceuticals Private Limited (₹51.2 Lakh).
Vijay Mathodu Eshwarappa has expertise in General Business.
Vijay Mathodu Eshwarappa has 11 years in corporate governance.
By reported revenue, the largest current company of Vijay Mathodu Eshwarappa is Impilo Pharmaceuticals Private Limited, with revenue of ₹51.2 Lakh (FY 2019).
Vijay Mathodu Eshwarappa currently holds positions at 1 company: Impilo Pharmaceuticals Private Limited (₹51.2 Lakh).